• Strategic Technologies

BIA letter to the Chancellor ahead of the 2019 Spending Round

The BIA has written to the Chancellor ahead of the 2019 Spending Round to highlight how the Government should maintain a competitive life sciences environment in the UK. 

Leading Innovation|The UK's ATMP Landscape

The Alliance for Regenerative Medicine (ARM) and the BioIndustry Association (BIA) have published a report setting out the scope of the UK’s robust and growing Advanced Therapy Medicinal Products (ATMPs) sector which includes the development of potentially transformative cell and gene therapies.

Influencing and shaping our sector | BIA update: April - July 2019

The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from April to July 2019.

BIA response to the Science and Technology Committee’s inquiry on commercial genomics

The BIA has responded to the House of Commons Science and Technology Select Committee’s inquiry on commercial genomics.